CEO
Peter has over 40 years’ experience in healthcare and life sciences, having qualified in Pathology, with a Masters in both Clinical, Biochemistry and Immunology and an Executive MBA from Kellogg School of Management, Northwestern University Chicago.
In 2017 he stepped down from running Clinigen plc to found Enigma Holdings, an investment company that specialises in health, wellbeing, sport, learning, community and social housing, and XPG Ltd an investment company focused on property.
Clinigen Group plc is a company he started in 2010 as a global specialty pharmaceuticals and pharma services business and floated in 2012; being one of the most successful floats on the AIM stock market.
In addition to Enigma Holdings and XPG, Peter currently holds a number of public and private company roles; Chairman of Benchmark Holdings PLC, NED at Osler Diagnostics, advisor at Clinigen Group, Ergomed plc, Gresham House and Oxford Sciences Innovations plc.
Book an Appointment